NHS introduces ‘artificial pancreas’ to revolutionise diabetes management
The NHS in England is set to provide an 'artificial pancreas' to tens of thousands of individuals grappling with type 1 diabetes.
Addressing the true causes of obesity
Lorna Rothery spoke to Jacqueline Bowman-Busato, Head of Policy at the European Association for the Study of Obesity (EASO), to find out the true...
Time for Europe to prioritise preventative health
Vaccine confidence has fallen to pre-pandemic levels but, says Sibilia Quilici, Executive Director of Vaccines Europe, there is a need and value in boosting...
Nurses need greater support to embrace the digital revolution
An upsurge in digital skills training and support for nurses is required if full benefit is to be gained from the digital revolution.
The implications of antibiotic use in farming
Jane Tredgett, Campaigns Manager at Alliance to Save Our Antibiotics, discusses the effects of routine antibiotic use in intensive livestock farming and why it...
Defence Therapeutics announces successful ARM-002TM cancer vaccine results
Defence Therapeutics has announced the successful testing of its second-generation anti-cancer vaccine, named ARM-002TM, utilising its flagship anti-cancer molecule, AccuTOX®.
The ARM-002TM cancer vaccine, when...
Healing the health workforce: A call to action for EU institutions
Mariano Votta, Director of Active Citizenship Network, is calling on new EU Institutions to tackle the health workforce crisis.
Civil organisations, patients' advocacy groups (PAGs),...
NHS pilot trials lung cancer blood test across thousands of patients
The NHS is conducting trials for a groundbreaking lung cancer blood test to detect the disease at its earliest stages.
Study reveals the mechanism behind COVID brain fog
A team of US researchers has potentially uncovered the cause of COVID brain fog and may help identify treatments.
Hydrogel innovation transforms stem cell therapy for Parkinson’s disease
A team of University of Galway neuroscientists have made a significant breakthrough in optimising stem cell therapy for Parkinson's disease.
Scientists identify protein interface that drives cancer growth
For the first time, researchers have shown that the protein interface that drives cancer growth could act as a target for more effective treatments.
Led...
NHS waiting list continues to fall as staff tackle COVID backlog
NHS waiting lists and the COVID backlog fell for the fourth month in a row in January despite strike interruptions.
Can reducing social media use improve health and well-being?
Health Europa looks at how reducing your social media use can boost your health and happiness.
The rapid proliferation of social media in recent years...
Scientists pioneer new antimicrobial drugs from food by-products
Scientists are set to harness the potential of food by-products to manufacture antimicrobial drugs from bacteria.
NHS launches MMR vaccine catch-up campaign
The NHS in England has embarked on a campaign to ensure that more than 900,000 adults aged 19 to 25 receive their missed MMR...
European Patients’ Rights Day: Addressing skills shortage, medical desertification and job strain
Ahead of European Patients' Rights Day, Mariano Votta, Director of Active Citizenship Network, discusses how the event will tackle the skills shortage, medical desertification...
How UK nurses moving to Australia is bleeding the NHS dry
The exodus of UK nurses moving to Australia is becoming increasingly prevalent, accounting for a substantial proportion of nursing staff who have left the...
AstraZeneca to invest £650m in UK’s life sciences sector
Pharmaceutical giant AstraZeneca has revealed plans to inject £650m into the UK, bolstering the nation's life sciences sector and propelling economic growth.
This significant investment...
Pharmaceutical pollution – the blue healthcare revolution
Dr Kelly Thornber, Post-Doctoral Research Fellow at the University of Exeter, discusses the key drivers of pharmaceutical pollution and its impact.
In 2020 the UK’s...
New endometrial cancer immunotherapy approved by the NHS
The NHS is set to introduce an immunotherapy that could potentially provide significant additional time for women battling endometrial cancer.